ArticleFrontiers in nutrition2025
Association between metabolic score for visceral fat and chronic pain: a cross-sectional analysis of NHANES 1999-2004.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic score for visceral fat as a superior predictor of frailty in overweight and obese adults: a cross-sectional NHANES analysis (2007-2020).Diabetology & metabolic syndrome · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Metabolic Score for Visceral Fat (METS-VF) offers a refined measure of visceral adiposity, potentially surpassing traditional metrics. This study examines the association between METS-VF and chronic pain in U.S. adults. Methods: We analyzed data from 5,905 adults aged 18 years and older from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Weighted multivariate linear regression and restricted cubic spline analyses were conducted to investigate the linear associations between METS-VF and chronic pain. Threshold effects were determined using a two-part linear regression model. Subgroup analyses were conducted across three age groups (18-39, 40-64, and ≥65 years). The predictive accuracy of METS-VF, body mass index (BMI), and waist circumference (WC) was evaluated using ROC curve analysis. Influential predictors of chronic pain were identified via XGBoost, and mediation analysis assessed the role of C-reactive protein (CRP). Results: Among participants (mean age, 46.8 years; 50.8% female), chronic pain prevalence was 14.6%. Higher METS-VF was associated with increased odds of chronic pain (adjusted OR per unit increase, 1.46; 95% CI, 1.13-1.87), with a threshold effect at METS-VF 5.714. The highest METS-VF quartile showed greater odds of chronic pain (OR, 1.87; 95% CI, 1.28-2.72; Conclusion: METS-VF independently associated with higher odds of chronic pain, especially in older adults.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.